Replies to post #661 on Lipocine Inc (LPCN)

[gi197845]

Yes, I think eventually we'll make a profit with this investment.

Hopefully, there won't be a drastic, secondary offering, which causes massive dilution, for the sake of generating funding capital to market Tlando.

Hopefully, there won't be any toxic financing, for the sake of funding capital to market Tlando.

Hopefully, there won't be a drastic reverse split, for the sake of funding capital to market Tlando.

Hopefully, we'll get a good marketing/sales pharma partner.

Better yet, hopefully there will be a big pharma buy out, after Tlando is approved, after good Nash phase II results are released in January.

Hopefully, a bigger pharma will have no issue fighting in court and will do the buy out before the court cases are settled.

Otherwise, Lipocine may have to wait until the court cases are settled and won by Lipocine, before any big pharma offers a buy out.

It can be problematic for investors, when a development biotech pharma tries to make the move into a marketing/selling pharma...